At Elucid, our mission is to advance quantitative imaging and integrative medical science for the benefit of patients. We develop products and services to better inform medical decisions and manage individual patients and to improve the effectiveness of clinical trials of novel therapies.

Our revolutionary development platform QI-Bench provides the means for rigorously exploiting potentially massive data sets to transform radiological imaging for the 21st century with reproducible science.

Our flagship atherosclerosis product vascuCAP™ challenges the status quo by thinking differently to provide the world's burgeoning baby boomer population with a non-invasive and effective biomarker that stratifies dangerous atherosclerotic plaques to save lives and reduce disability due to stroke and heart attack.